- Report
- July 2024
- 111 Pages
Asia Pacific
From €1373EUR$1,500USD£1,167GBP
- Report
- July 2024
- 110 Pages
Africa, Middle East
From €1373EUR$1,500USD£1,167GBP
- Report
- April 2018
- 470 Pages
Global
From €2746EUR$3,000USD£2,334GBP
- Report
- November 2023
- 131 Pages
Global
From €4257EUR$4,650USD£3,618GBP
- Report
- September 2023
- 100 Pages
Global
From €5447EUR$5,950USD£4,629GBP
- Report
- May 2024
- 132 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 130 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 135 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 131 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 138 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2022
- 120 Pages
Global
From €4074EUR$4,450USD£3,462GBP
- Report
- June 2022
- 114 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- January 2024
- 143 Pages
Global
From €7277EUR$7,950USD£6,185GBP
- Report
- January 2022
- 60 Pages
Global
From €3616EUR$3,950USD£3,073GBP
- Report
- January 2022
- 60 Pages
Global
From €3616EUR$3,950USD£3,073GBP
- Report
- January 2022
- 60 Pages
Global
From €3616EUR$3,950USD£3,073GBP
- Report
- January 2022
- 60 Pages
Global
From €3616EUR$3,950USD£3,073GBP
- Report
- January 2022
- 60 Pages
Global
From €3616EUR$3,950USD£3,073GBP
- Report
- January 2022
- 60 Pages
Global
From €3616EUR$3,950USD£3,073GBP
- Report
- January 2022
- 60 Pages
Global
From €3616EUR$3,950USD£3,073GBP

The Melanoma Drug market is a subset of the larger Skin Cancer Drugs market. It is composed of drugs used to treat melanoma, a type of skin cancer. These drugs are typically used in combination with other treatments such as surgery, radiation, and immunotherapy. Commonly used drugs include targeted therapies, immunotherapies, and chemotherapy. Targeted therapies are designed to target specific molecules in the cancer cells, while immunotherapies are designed to boost the body's own immune system to fight the cancer. Chemotherapy is used to kill cancer cells.
The Melanoma Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck, Roche, Novartis, and Pfizer. Other companies include AstraZeneca, Eli Lilly, and GlaxoSmithKline. Show Less Read more